Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort
Jefferson C, Watson E, Certa J, Gordon K, Park L, D’Souza G, Benning L, Abraham A, Agil D, Napravnik S, Silverberg M, Leyden W, Skarbinski J, Williams C, Althoff K, Horberg M, Team O. Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort. PLOS ONE 2022, 17: e0276742. PMID: 36417366, PMCID: PMC9683575, DOI: 10.1371/journal.pone.0276742.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 testingRace/ethnicityRelative risk ratiosAdverse outcomesCOVID-19 testingHealth system typesWhite patientsBlack patientsUS cohortCOVID-19-related hospitalizationAsian/Pacific Islander patientsDiverse US cohortPacific Islander patientsLow positivity rateCOVID-19 pandemicEvidence of disparitiesElectronic health recordsCohort CollaborationHispanic patientsPatient reportingPrimary exposureRisk ratioRisk factorsPositivity rateHigh burden